Mitral Valve Prolapse
Mitral valve prolapse (MVP) is a condition where the mitral valve doesn't close properly, which can lead to symptoms like palpitations, chest pain, and fatigue. It is often benign but can sometimes cause arrhythmias.
Arrhythmic Mitral Valve Prolapse: Flecainide and Metoprolol Study
We are studying whether adding flecainide to metoprolol can better reduce irregular heartbeats in patients with arrhythmic mitral valve prolapse. This trial aims to assess the safety and effectiveness of this combination treatment.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you 18 years old or older?
- Do you have mitral valve prolapse (a heart condition) diagnosed by a doctor?
- Are you currently pregnant or breastfeeding?
- Are you taking any medications that include flecainide or metoprolol?
- Do you have any heart failure symptoms or have you been diagnosed with heart failure?
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Oslo University Hospital Hf
Department of Cardiology
Oslo, Norway
Sponsor: Oslo University Hospital Hf
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.